Altimmune (ALT) Prepaid Assets (2010 - 2026)
Altimmune (ALT) reported Prepaid Assets of $1.4 million for Q1 2026, down 51.23% year-over-year from $2.9 million in Q1 2025, and down 51.67% on a QoQ basis from $3.0 million in Q4 2025.
Altimmune (ALT) has 17 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Prepaid Assets fell 51.23% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 51.23% YoY) and the FY2025 annual result came in at $3.0 million, up 34.17% from the prior year.
- Prepaid Assets eased to $1.4 million in Q1 2026 per ALT's latest filing, from $3.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.6 million in Q3 2023 and bottomed at $1.4 million in Q1 2026.
- The 5-year median for Prepaid Assets is $4.4 million (2025), against an average of $4.2 million.
- The widest annual swing landed in 2023, when Prepaid Assets jumped 58.98%; it then tumbled 68.14% in 2024.
- Tracing ALT's Prepaid Assets over 5 years: stood at $5.4 million in 2022, then gained by 29.1% to $6.9 million in 2023, then plunged by 68.14% to $2.2 million in 2024, then surged by 34.17% to $3.0 million in 2025, then sank by 51.67% to $1.4 million in 2026.
- Per Business Quant, the three latest ALT Prepaid Assets figures stand at $1.4 million (Q1 2026), $3.0 million (Q4 2025), and $4.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 6.92 Mn |
| Sep 30, 2023 | 7.62 Mn |
| Jun 30, 2023 | 5.82 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 5.36 Mn |
| Sep 30, 2022 | 4.79 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Dec 31, 2021 | 7.95 Mn |
| Sep 30, 2021 | 7.29 Mn |
| Jun 30, 2021 | 9.41 Mn |
| Mar 31, 2021 | 5.95 Mn |
| Dec 31, 2020 | 1.93 Mn |
| Sep 30, 2020 | 1.31 Mn |
| Jun 30, 2020 | 1.02 Mn |
| Mar 31, 2020 | 698,905.00 |
| Dec 31, 2019 | 470,228.00 |
| Sep 30, 2019 | 410,148.00 |
| Jun 30, 2019 | 688,862.00 |
| Mar 31, 2019 | 505,949.00 |
| Dec 31, 2018 | 548,094.00 |
| Sep 30, 2018 | 443,929.00 |
| Jun 30, 2018 | 677,478.00 |
| Mar 31, 2018 | 1.45 Mn |
| Dec 31, 2017 | 994,332.00 |
| Sep 30, 2017 | 1.01 Mn |
| Jun 30, 2017 | 1.45 Mn |
| Mar 31, 2017 | 467,642.00 |
| Dec 31, 2016 | 420,424.00 |
| Sep 30, 2016 | 509,857.00 |
| Jun 30, 2016 | 418,636.00 |
| Mar 31, 2016 | 463,873.00 |
| Dec 31, 2015 | 181,714.00 |
| Sep 30, 2015 | 196,478.00 |
| Jun 30, 2015 | 316,014.00 |
| Mar 31, 2015 | 446,240.00 |
| Dec 31, 2014 | 199,194.00 |
| Jun 30, 2014 | 550,979.00 |
| Mar 31, 2014 | 401,448.00 |
| Dec 31, 2013 | 231,491.00 |
| Sep 30, 2013 | 209,514.00 |
| Jun 30, 2013 | 667,850.00 |
| Mar 31, 2013 | 614,388.00 |
| Dec 31, 2012 | 547,245.00 |
| Sep 30, 2012 | 363,742.00 |
| Jun 30, 2012 | 675,047.00 |
| Mar 31, 2012 | 802,080.00 |
| Dec 31, 2011 | 830,585.00 |
| Sep 30, 2011 | 470,666.00 |
| Jun 30, 2011 | 301,639.00 |
| Dec 31, 2010 | 1.35 Mn |